Efficacy of the Mineral Oil and Hyaluronic Acid Mixture Eye Drops in Murine Dry Eye
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: To investigate the therapeutic effects of mineral oil (MO) and hyaluronic acid (HA) mixture eye drops on the tear film and ocular surface in a mouse model of experimental dry eye (EDE). Methods: Eye drops consisting of 0.1% HA alone or mixed with 0.1%, 0.5%, or 5.0% MO were applied to desiccating stress-induced murine dry eyes. Tear volume, corneal irregularity score, tear film break-up time (TBUT), and corneal fluorescein staining scores were measured at 5 and 10 days after treatment. Ten days after treatment, goblet cells in the conjunctiva were counted after Periodic acid-Schiff staining. Results: There was no significant difference in the tear volume between desiccating stress-induced groups. The corneal irregularity score was lower in the 0.5% MO group compared with the EDE and HA groups. The 0.5% and 5.0% MO groups showed a significant improvement in TBUT compared with the EDE group. Mice treated with 0.1% and 0.5% MO mixture eye drops showed a significant improvement in fluorescein staining scores compared with the EDE group and the HA group. The conjunctival goblet cell count was higher in the 0.5% MO group compared with the EDE group and HA group. Conclusions: The MO and HA mixture eye drops had a beneficial effect on the tear films and ocular surface of murine dry eye. The application of 0.5% MO and 0.1% HA mixture eye drops could improve corneal irregularity, the corneal fluorescein staining score, and conjunctival goblet cell count compared with 0.1% HA eye drops in the treatment of EDE.
Abstract
Purpose: To investigate the therapeutic effects of mineral oil (MO) and hyaluronic acid (HA) mixture eye drops on the tear film and ocular surface in a mouse model of experimental dry eye (EDE). Methods: Eye drops consisting of 0.1% HA alone or mixed with 0.1%, 0.5%, or 5.0% MO were applied to desiccating stress-induced murine dry eyes. Tear volume, corneal irregularity score, tear film break-up time (TBUT), and corneal fluorescein staining scores were measured at 5 and 10 days after treatment. Ten days after treatment, goblet cells in the conjunctiva were counted after Periodic acid-Schiff staining. Results: There was no significant difference in the tear volume between desiccating stress-induced groups. The corneal irregularity score was lower in the 0.5% MO group compared with the EDE and HA groups. The 0.5% and 5.0% MO groups showed a significant improvement in TBUT compared with the EDE group. Mice treated with 0.1% and 0.5% MO mixture eye drops showed a significant improvement in fluorescein staining scores compared with the EDE group and the HA group. The conjunctival goblet cell count was higher in the 0.5% MO group compared with the EDE group and HA group. Conclusions: The MO and HA mixture eye drops had a beneficial effect on the tear films and ocular surface of murine dry eye. The application of 0.5% MO and 0.1% HA mixture eye drops could improve corneal irregularity, the corneal fluorescein staining score, and conjunctival goblet cell count compared with 0.1% HA eye drops in the treatment of EDE.
참고문헌 (34)
- "The definition and classification of dry eye disease", report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop, 5, pp.75~92 (2007)
- Cuevas M, "Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD)", Curr Eye Res, 37, pp.855~863 (2012)
- Gupta H, "Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system", Drug Deliv, 14, pp.507~515 (2007)
- Behrens A, "Dysfunctional tear syndrome:a Delphi approach to treatment recommendations", Cornea, 25, pp.900~907 (2006)
- McCann LC, "Effectiveness of artificial tears in the management of evaporative dry eye", Cornea, 31, pp.1~5 (2012)
- McDonald CC, "A randomised, crossover, multicentre study to compare the performance of 0.1% (w", v) sodium hyaluronate with 1.4% (w, Eye (Lond), pp.2002, 16[DOI]
- Wysenbeek YS, "The effect of sodium hyaluronate on the corneal epithelium. An ultrastructural study", Invest Ophthalmol Vis Sci, 29, pp.194~199 (1988)
- Sand BB, "Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial", Acta Ophthalmol (Copenh), 67, pp.181~183 (1989)
- DeLuise VP, "The use of topical Healon tears in the management of refractory dry-eye syndrome", Ann Ophthalmol, 16, pp.823~824 (1984)
- Stuart JC, "Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders", Ann Ophthalmol, 17, pp.190~192 (1985)
- Rawlings AV, "A review on the extensive skin benefits of mineral oil", Int J Cosmet Sci, 34, pp.511~518 (2012)
- Wang IJ, "A comparison of the effect of carbomer-, cellulose- and mineral oil-based artificial tear formulations", Eur J Ophthalmol, 17, pp.151~159 (2007)
- Yoon KC, "Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice", J Autoimmun, 30, pp.212~221 (2008)
- Niederkorn JY, "Desiccating stress induces T cell-mediated Sjogren’s Syndrome-like lacrimal keratoconjunctivitis", J Immunol, 176, pp.3950~3957 (2006)
- De Paiva CS, "Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye", Exp Eye Res, 83, pp.526~535 (2006)
- De Paiva CS, "Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma", Invest Ophthalmol Vis Sci, 48, pp.2553~2560 (2007)
- Villareal AL, "Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice", Eye Contact Lens, 32, pp.272~276 (2006)
- Li Z, "Effectiveness of topical infliximab in a mouse model of experimental dry eye", Cornea, 31(1), pp.25~31 (2012)
- Li Z, "Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye", Invest Ophthalmol Vis Sci, 54, pp.155~162 (2013)
- De Paiva CS, "Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline", Invest Ophthalmol Vis Sci, 47, pp.2847~2856 (2006)
- Dogru M, "Tear function and ocular surface changes with topical mitomycin (MMC)treatment for primary corneal intraepithelial neoplasia", Cornea, 22, pp.627~639 (2003)
- Xiao X, "Therapeutic effects of epidermal growth factor on benzalkonium chloride-induced dry eye in a mouse model", Invest Ophthalmol Vis Sci, 53, pp.191~197 (2012)
- Vogel R, "Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena)", Am J Ophthalmol, 149, pp.594~601 (2010)
- Brignole F, "Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis", Graefes Arch Clin Exp Ophthalmol, 243, pp.531~538 (2005)
- Nakamura M, "Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan", Curr Eye Res, 11, pp.981~986 (1992)
- Stern ME, "The pathology of dry eye: the interaction between the ocular surface and lacrimal glands", Cornea, 17, pp.584~589 (1998)
- Adamia S, "Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer", Curr Drug Targets Cardiovasc Haematol Disord, 5, pp.3~14 (2005)
- Turino GM, "Hyaluronan in respiratory injury and repair", Am J Respir Crit Care Med, 167, pp.1169~1175 (2003)
- Toole BP, "Hyaluronan promotes the malignant phenotype", Glycobiology, 12, pp.37~42 (2002)
- Lerner LE, "Hyaluronan and CD44 in the human cornea and limbal conjunctiva", Exp Eye Res, 67, pp.481~484 (1998)
- Sullivan LJ, "Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome", Ophthalmology, 104, pp.1402~1408 (1997)
- Wang TJ, "Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study", Clin Ther, 32, pp.44~52 (2010)
- Holly FJ, "Artificial tear formulations", Int Ophthalmol Clin, 20, pp.171~184 (1980)
- Scifo C, "Effects of a new lipid tear substitute in a mouse model of dry eye", Cornea, 29, pp.802~806 (2010)